290 related articles for article (PubMed ID: 18365391)
1. Characterization of anti-HLA antibodies eluted from explanted renal allografts.
Heinemann FM; Roth I; Rebmann V; Arnold ML; Spriewald BM; Grosse-Wilde H
Clin Transpl; 2006; ():371-8. PubMed ID: 18365391
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.
Heinemann FM; Roth I; Rebmann V; Arnold ML; Witzke O; Wilde B; Spriewald BM; Grosse-Wilde H
Hum Immunol; 2007 Jun; 68(6):500-6. PubMed ID: 17509449
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Detection and specification of noncomplement binding anti-HLA alloantibodies.
Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
Arnold ML; Dechant M; Doxiadis II; Spriewald BM
Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
[TBL] [Abstract][Full Text] [Related]
6. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
[TBL] [Abstract][Full Text] [Related]
7. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
[TBL] [Abstract][Full Text] [Related]
9. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.
Zou Y; Heinemann FM; Grosse-Wilde H; Sireci G; Wang Z; Lavingia B; Stastny P
Hum Immunol; 2006 Mar; 67(3):230-7. PubMed ID: 16698447
[TBL] [Abstract][Full Text] [Related]
11. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
12. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
[TBL] [Abstract][Full Text] [Related]
15. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
16. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
Schlaf G; Radam C; Wahle A; Altermann WW
Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
[TBL] [Abstract][Full Text] [Related]
17. HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study.
Langan LL; D'Orsogna L; Park LP; Hughes TL; Irish A; Luxton G; Witt CS; Christiansen FT
Clin Transpl; 2006; ():219-25. PubMed ID: 18365380
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
[TBL] [Abstract][Full Text] [Related]
19. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
[TBL] [Abstract][Full Text] [Related]
20. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study.
Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C
Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
